These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 32303565)

  • 1. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
    Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
    Harrington A; Cox B; Snowdon J; Bakst J; Ley E; Grajales P; Maggiore J; Kahn S
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32327448
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.
    Rhoads DD; Cherian SS; Roman K; Stempak LM; Schmotzer CL; Sadri N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303564
    [No Abstract]   [Full Text] [Related]  

  • 6. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2.
    Creager HM; Cabrera B; Schnaubelt A; Cox JL; Cushman-Vokoun AM; Shakir SM; Tardif KD; Huang ML; Jerome KR; Greninger AL; Drobysheva D; Spaulding U; Rogatcheva M; Bourzac KM; Hinrichs SH; Broadhurst MJ; Fey PD
    J Clin Virol; 2020 Aug; 129():104538. PubMed ID: 32650276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
    Hou H; Chen J; Wang Y; Lu Y; Zhu Y; Zhang B; Wang F; Mao L; Tang YW; Hu B; Ren Y; Sun Z
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32503847
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Commercially Available and Laboratory-Developed Assays for
    Lieberman JA; Pepper G; Naccache SN; Huang ML; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32350048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
    Zhen W; Smith E; Manji R; Schron D; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32332061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays.
    Lowe CF; Matic N; Ritchie G; Lawson T; Stefanovic A; Champagne S; Leung V; Romney MG
    J Clin Virol; 2020 Jul; 128():104387. PubMed ID: 32380382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay.
    Wong RC; Wong AH; Ho YI; Leung EC; Lai RW
    J Clin Virol; 2020 Oct; 131():104593. PubMed ID: 32823131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay.
    Goldenberger D; Leuzinger K; Sogaard KK; Gosert R; Roloff T; Naegele K; Cuénod A; Mari A; Seth-Smith H; Rentsch K; Hinić V; Hirsch HH; Egli A
    J Virol Methods; 2020 Oct; 284():113925. PubMed ID: 32659240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
    Smithgall MC; Scherberkova I; Whittier S; Green DA
    J Clin Virol; 2020 Jul; 128():104428. PubMed ID: 32434706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
    Lambert-Niclot S; Cuffel A; Le Pape S; Vauloup-Fellous C; Morand-Joubert L; Roque-Afonso AM; Le Goff J; Delaugerre C
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404480
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.
    Dust K; Hedley A; Nichol K; Stein D; Adam H; Karlowsky JA; Bullard J; Van Caeseele P; Alexander DC
    J Virol Methods; 2020 Nov; 285():113970. PubMed ID: 32920028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
    Stevens B; Hogan CA; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
    J Appl Lab Med; 2020 Nov; 5(6):1307-1312. PubMed ID: 32761092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.